Global Circulating Tumor Cells (CTC) Market Analysis 2019

  • ID: 4746752
  • Report
  • Region: Global
  • 121 pages
  • Syngene Research
1 of 4

FEATURED COMPANIES

  • ApoCell, Inc. (US)
  • Biocep Ltd. (Israel)
  • F. Hoffmann-La Roche Ltd
  • Fluxion Biosciences, Inc.
  • GE Healthcare
  • Ikonisys Inc.
  • MORE
The Global Circulating Tumor Cells (CTC) market is expected to reach $44,523.31 Million by 2026 growing at a CAGR of 18.7% during 2018 to 2026. The Circulating Tumor Cells refers to the tumor cells, which are circulating inside the body through blood circulation system and lymphatic system. These are significantly useful in determining the status of disease progression rate and projection of therapy needed for tumor eradication. Further developments of various tumor markers that can be used along with companion diagnostics to diagnose or monitor various forms of cancer are driving the market growth. However, factors such as Lack of awareness and reluctance for the adoption of advanced CTC technologies are restricting the market growth. The growing demand for faster diagnosis and innovation in CTC technology are offering significant growth opportunities for the market growth.

Based on Technology, the CTC Enrichment Methods segment attributed by advancements of enriched CTCs enable their functional characterization which is critical for disease interrogation and target therapy thus leading to raise the demand for enrichment technology. High usage rates in biotechnology research establishments and high accuracy exhibited by this technology are some key factors expected to drive market growth in the forecast period.

The key vendors mentioned are Thermo Fisher Scientific, STEMCELL Technologies, SRI International, QIAGEN Hannover (QIAGEN), NanoString Technologies, Inc., Miltenyi Biotec, Menarini Silicon Biosystems, Ikonisys Inc., Greiner Bio-One International GmbH, GE Healthcare, Fluxion Biosciences, Inc., F. Hoffmann-La Roche Ltd, Biofluidica Microtechnologies LLC (US), Biocep Ltd. (Israel) and ApoCell, Inc. (US).

Technologies Covered:
  • CTC Detection Methods
  • CTC Enrichment Methods
  • Combined Enrichment And Separation Of CTC (CTC Analysis)
Applications Covered:
  • Epithelial-Mesenchymal Transition (EMT) Biomarkers Development
  • Cancer Cell Research
  • Other Applications
End Users Covered:
  • Research & Academic Institutes
  • Hospital & Clinics
  • Diagnostic Centers
Key Questions Answered in this Report:
  • How this market evolved since the year 2016
  • Market size estimations, forecasts and CAGR for all the segments presented in the scope
  • Key Market Developments and financials of the key players
  • Opportunity Analysis for the new entrants
  • SWOT Analysis of the key players
  • Fastest growing markets analysed during the forecast period
*Please Note: This report will be delivered within 48 hours of ordering.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • ApoCell, Inc. (US)
  • Biocep Ltd. (Israel)
  • F. Hoffmann-La Roche Ltd
  • Fluxion Biosciences, Inc.
  • GE Healthcare
  • Ikonisys Inc.
  • MORE
1 Market Synopsis

2 Research Outline
2.1 Research Snapshot
2.2 Research Methodology
2.3 Research Sources
2.3.1 Primary Research Sources
2.3.2 Secondary Research Sources

3 Market Dynamics
3.1 Drivers
3.2 Restraints

4 Market Environment
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Circulating Tumor Cells (CTC) Market, By Technology
5.1 Introduction
5.2 CTC Detection Methods
5.3 CTC Enrichment Methods
5.4 Combined Enrichment And Separation Of CTC (CTC Analysis)

6 Global Circulating Tumor Cells (CTC) Market, By Application
6.1 Introduction
6.3 Epithelial-Mesenchymal Transition (EMT) Biomarkers Development
6.4 Cancer Cell Research
6.5 Other Applications

7 Global Circulating Tumor Cells (CTC) Market, By End User
7.1 Introduction
7.2 Research & Academic Institutes
7.3 Hospital & Clinics
7.4 Diagnostic Centers

8 Global Circulating Tumor Cells (CTC) Market, By Geography
8.1 Introduction
8.2 North America
8.3 Europe
8.4 Asia Pacific
8.5 South America
8.6 Middle East & Africa

9 Strategic Benchmarking

10 Vendors Landscape
10.1 Thermo Fisher Scientific
10.2 STEMCELL Technologies
10.3 SRI International
10.4 QIAGEN Hannover (QIAGEN)
10.5 NanoString Technologies, Inc.
10.6 Miltenyi Biotec
10.7 Menarini Silicon Biosystems
10.8 Ikonisys Inc.
10.9 Greiner Bio-One International GmbH
10.10 GE Healthcare
10.11 Fluxion Biosciences, Inc.
10.12 F. Hoffmann-La Roche Ltd
10.13 Biofluidica Microtechnologies LLC (US)
10.14 Biocep Ltd. (Israel)
10.15 ApoCell, Inc. (US)

List of Data Tables
Table 1 Global Circulating Tumor Cells (CTC) Market Outlook, By Region (2016-2026) ($MN)
Table 2 Global Circulating Tumor Cells (CTC) Market Outlook, By Technology (2016-2026) ($MN)
Table 3 Global Circulating Tumor Cells (CTC) Market Outlook, By CTC Detection Methods (2016-2026) ($MN)
Table 4 Global Circulating Tumor Cells (CTC) Market Outlook, By CTC Enrichment Methods (2016-2026) ($MN)
Table 5 Global Circulating Tumor Cells (CTC) Market Outlook, By Combined Enrichment And Separation Of CTC (CTC Analysis) (2016-2026) ($MN)
Table 6 Global Circulating Tumor Cells (CTC) Market Outlook, By Application (2016-2026) ($MN)
Table 7 Global Circulating Tumor Cells (CTC) Market Outlook, By Epithelial-Mesenchymal Transition (EMT) Biomarkers Development (2016-2026) ($MN)
Table 8 Global Circulating Tumor Cells (CTC) Market Outlook, By Cancer Cell Research (2016-2026) ($MN)
Table 9 Global Circulating Tumor Cells (CTC) Market Outlook, By Other Applications (2016-2026) ($MN)
Table 10 Global Circulating Tumor Cells (CTC) Market Outlook, By End User (2016-2026) ($MN)
Table 11 Global Circulating Tumor Cells (CTC) Market Outlook, By Research & Academic Institutes (2016-2026) ($MN)
Table 12 Global Circulating Tumor Cells (CTC) Market Outlook, By Hospital & Clinics (2016-2026) ($MN)
Table 13 Global Circulating Tumor Cells (CTC) Market Outlook, By Diagnostic Centers (2016-2026) ($MN)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Thermo Fisher Scientific
  • STEMCELL Technologies
  • SRI International
  • QIAGEN Hannover (QIAGEN)
  • NanoString Technologies, Inc.
  • Miltenyi Biotec
  • Menarini Silicon Biosystems
  • Ikonisys Inc.
  • Greiner Bio-One International GmbH
  • GE Healthcare
  • Fluxion Biosciences, Inc.
  • F. Hoffmann-La Roche Ltd
  • Biofluidica Microtechnologies LLC (US)
  • Biocep Ltd. (Israel)
  • ApoCell, Inc. (US)
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4746752
Adroll
adroll